Straw Phonation for Voice Fatigue

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
University of Utah, Salt Lake City, UT
Voice Fatigue+3 More
Straw phontion - Behavioral
Eligibility
18+
All Sexes
What conditions do you have?
Select

Study Summary

To investigate the change in fundamental frequency range and vocal fold stability achievable with vocal fold stretching exercise in human populations with high and low vocal activity

Eligible Conditions

  • Voice Fatigue
  • Hoarseness

Treatment Effectiveness

Effectiveness Progress

1 of 3

Study Objectives

1 Primary · 2 Secondary · Reporting Duration: 3 months following treatment.

3 months following intervention
Voice Range Profile (VRP)
3 months following treatment.
Acoustic measurement
Electroglottography (EGG)

Trial Safety

Safety Progress

1 of 3

Trial Design

1 Treatment Group

Straw Phonation
1 of 1
Experimental Treatment

120 Total Participants · 1 Treatment Group

Primary Treatment: Straw Phonation · No Placebo Group · N/A

Straw Phonation
Behavioral
Experimental Group · 1 Intervention: Straw phontion · Intervention Types: Behavioral

Trial Logistics

Trial Timeline

Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: 3 months following treatment.

Trial Background

Amanda Stark, Research Associate
Principal Investigator
University of Utah
Closest Location: University of Utah · Salt Lake City, UT
Photo of ut university of utah  1Photo of ut university of utah  2Photo of ut university of utah  3
2006First Recorded Clinical Trial
1 TrialsResearching Voice Fatigue
670 CompletedClinical Trials

Eligibility Criteria

Age 18+ · All Participants · 3 Total Inclusion Criteria

Mark “yes” if the following statements are true for you:
You have no current voice disorder.
You must be at least 18 years old to participate in this study.

About The Reviewer

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 9th, 2021

Last Reviewed: August 12th, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.